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Leu-S is a novel antigen expressed by the majority of ma-
ture T cell s and certain o ther cell s. Recent studies of the 
allogeneic mixed leukocyte reaction indica te th at bo th Leu-
S+ and Leu-S - subsets of Leu-3+ T cell s have important 
fun ctions in cell-mediated immuni ty in vitro. In o rder to 
determine w hether Leu-3 +S+ and /o r Leu-3 +S- T ce ll s are 
present in cell-mediated immune reactions in vivo, we studied 
the immuno histology of allergic contact dermatiti s in S 
biopsies from S patients with positive patch tests and 3 
biopsies from 2 patients with Rhus dermatitis. Both Leu-
3+S + and Leu-3 +S- T cell s were present in each biopsy . 
Only 1 case had a definite min ority of the Leu-3 +S+ subset. 
U sin g the allogeneic mi xed leukocytc rea.ction (MLR) as a model of T-cell regulation in vitro, rcccn t swdies have dcm onstrated that T-cell subsets dc-fined by react ivity w ith murine antihuman m ono-clonal an tibodies anti-Lcu-3 and anti-Leu-S cxhibit 
specific functi ons [1 -3] (Table I). The Leu-3+S+ subset conta ins 
indu cer T cells (TI) wh ich are res ponsiblc for th e generation of 
cy to toxic T cells (T c) and sup pressor T cells (Ts), both of w hich 
belong to th e Leu-2 + T -cell subset. T I also promote thc differ-
entiation of amplifier T cclls (T A) as dcscribed below. Further-
m ore, they have been postu lated to activate sccondary o r sub-
ordinatc T - ceU circuits throu gh their action upon fresh auto logous 
Leu-3 +S+ T cells. T he Leu-3+S - subset contains TA w hi ch aug-
ment the differenti ation of T s, but onl y in the presencc of Leu-
3 +S + T I. Leu-3 +S - T cells also fun cti on as induccrs of T c and 
B-cell differentiati on . In the context of inducing 13-cell d iffer-
entiation, Leu-3 +S- T cclls are o ften referred to as hclpcr T 
cells (T H)' 
T hesc in vitro relationships suggest that bo th Lcu-3 ·r S+ and 
Leu-3 +S- T -cell subsets ma y bc in volved in cell-mediatcd im-
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Abbreviations: 
MLR: mixed leukocyte reaction 
N K: natural ki ller/ ki ller ce lls 
T A: amplifier T ce lls 
T c : cytotoxic T cells 
T cs: cy to toxic/suppressor T cells 
T H : helper T cel ls 
T I : inducer T cells 
T s: suppressor T ce lls 
T hese results sugges t that, analogous to in vitro sys tem s, 
both Leu-S + and Leu-S - subsets of Leu-3 + T cell s are 
in volved in ce ll-m ediated immunity in vivo. HLA-DR + 
keratinocytes w ere present in onl y 3 of 11 biopsies at da ys 
3-7. N o HLA-DQ + keratinocytes were identified. We also 
con firmed prior findin gs that Leu-3+ cell s are the predom-
inant T-cell population, Langerhans cell s are in creased, and 
B cells and NK cells are rare. Furtherm o re, Tac and Ki-67 
expression by T cell s and Leu-3 expression by La ngerhans 
cell s tended to in crease over tim e. J In vest Den'l'lato / 87:688-
693, 1986 
munity in vivo. We thcrefore assessed ·Leu-S exp ress ion in situ 
in skin biops ies fro m patients with pos iti ve patch tcsts or Rhu s 
dermatitis in o rder to determin e w hether one o r both Lcu-3 + 
subscts are prcsent in cell-mcdiated immune reactions, in vivo. 
In additi on to confirmin g prior obscrva ti ons rcgarding other 
T-cell and non-T -ccll pop ula tions, we also focused upon o ther 
para l11 cters w hi ch have becn problcmati c or un addrcssed in pre-
vious stud ies of allergic conta ct dermatitis. Thcsc included HLA-
DR and HLA-DQ ex pression by vari ous cells, Tac and Ki-67 
exp rcssion by T cells, and Leu-3 cx pression by Langcrhans cells. 
MATERIALS AND METH ODS 
Subjects Eight patients refc rred fo r cva lua tion by patch testing 
in th e Contact Derm atitis C lini c at Stanford wcre includcd in thi s 
study , in additi on to 2 paticnts rcferred for trea tment of Rhus 
derm at itis. Patients' ages ran ged fro lll 13-63 yea rs (mean = 41. 5 
years, med ian = 46.5 yca rs) . All sites se lected for biopsy showed 
cl ini ca l features typica l o f a 2 + to 3 + positi ve patch test with 
erythema, edema, and mi crovcs iculation to a va ri ety of allergens. 
Biopsies werc obtaincd w ith 3-l11m , 4-m m , o r 6-mm punches 
from pos itive patch test sitcs to ni ckcl (1 paticnt) at 2 days; to 
thim erosal, d ichromate, ros in , hydroxycitronellal (1 paticnt each) 
at 3 days; and to nco m ycin (1 paticn t) and quaterniul11 15 (2 
patients) at 7 days . In 1 paticnt w ith Rhus dcrn13t itis, simultaneous 
biopsies fo r immunophcnoty ping were obtaincd at 1 day from 2 
different lesional sites-an acutc cczcmatous vesicular dermatitis 
and an urtica ri al plaq ue. A sin gle biopsy of an acutc eczematous 
derm atitis w as obtaincd from thc other patient with Rhus der-
matiti s at 4 days. 
Immunohistology Pun ch biopsy spccimens from each patient 
we re placcd in refr igerated no rmal sa line and within a few hours 
wcre cry opres~ r vcd. T hey wcre subscquentl y scrial secti oned and 
stained with a 3-stage monoclona l antibody-bio tin-avidin im-
Illunoperoxidase tcchni quc including iso typc and background 
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Table I. Correlations Between T - Cell Phenotype 
and Functio n 
Phenotype Functiona l Subscts" 
Leu-2 + (CDS +) 
Leu-3 + (CD4 ·') 
Leu-3 '.!l + 
T ,T$ 
T ,. TA 
Inducer of T c. T s. T A 
In ducer of 2nd genl'l"3t ion T,? 
Inducer of T c , B 
Ampli fie r of T,. Ts 
"T - ccl l subse,s abbrev iated as fo ll ows: T c (cytotoxic). T s (sup pressor). '1', (i n-
ducer) . T, (a lll pli fier) . B: I:l cells. 
contro ls as described previo llsly [4J. T he pane l of m onoclonal 
an tibodies employed , along with their patterns of cell reactivity. 
are listed in Table II. Sections were coun tersta ined with meth ylene 
blue in o rder to vis ualize immunoperox id ase-nega tive cells. The 
tota l p e rcentage reactive with each antibody was es timated based 
upon microscopic exa min ation of lymp ho id cells in the en tire 
tissu e sectio n. T his was performed independently by 3 of us (ASV, 
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BJN , and GSW) . Weak ly Leu-3 ; m acrophages and Langerhans 
cell s were excl uded fro m Leu-3 + T-cell es timates. 
RESUL TS 
T he lymph o id infiltrate seen in all 11 specimens exa mined was 
CO lli posed almost exclusively ofT cells w ith a mature Leu-I +,4 + ,5 + 
phenotype. T-cell antigen express ion is deta il ed in Ta ble III. The 
res ults pertain to epider mis and dermis co m bi ned sin ce simil ar 
percen tages were o bserved in bo th co mpartments. In all cases a 
m ajo rity of T cells were Leu-9 + (range 60-90%, m edian 75%). 
In each specimen, the m ajor ity ofT cells comp risin g the infi ltrate 
were of the Leu-3 + helper/ ind ucer subset (range 67- 99%, m edian 
95%), and a mino rity of T cell s were of the Leu-2 + cyto-
tox ic/suppressor subset (ran ge 1-33%, m edian .s%). All biopsies 
contai ned Leu-3 ; ,8 + cells, as deduced from the fact that the num-
ber of Leu-8 + cells was always g reater than the number of Leu-
2 + cell s. T he percentage of Leu-8 I- cells ranged from 33-90% 
(median 60%) . O nl y 1 biopsy contained a min o rity ofLeu-3 +,8 ; 
cells. Representative immuno histologic find in gs arc illustrated in 
Fig 1. 
All bio psies contained HLA-DR ; and HLA-DQ + T cells (Fig 
Table II. M onoclo nal Antibody Pa nel 
Case 
lA . 
B. 
2. 
3. 
4. 
5. 
6. 
7. 
S. 
9. 
10. 
Antibodies 
Anti-Leu- I 
Anti- Leu-2 
Ant i-Lcu-3 
Anti- Leu-4 
Anti-Lcu-5 
Anti-Lcu-6 
Anti-Leu-7 
An ti-Leu-8 
Anti-Leu-9 
Anti- Leu- IO 
An ti- I-ILA-DR 
Anri-Tac 
Anti-Lcu-M3 
T015 
Ki-67 
Table III. 
Patch Test 
Allergen or 
Rhus Derm atitis 
Rhus dermatitis 
Rhus dermatitis 
Nickel 
T himerosa l 
Potassium dich romate 
r~ os in 
H ydroxyci troncllal 
Rhus dermatitis 
Quatcrni um 15 
Q uaterniulll1 5 
Neomycin 
C D Designation 
CD5 
C DS 
C D4 
CD3 
CD2 
CD I 
CD7 
CD25 
CD22 
Prcdominant Specificity 
Pan T cdl (> 95% T cell s) 
C yro tox iC/ su ppressor 
T cd l (15-30% T cd ls) 
Helper T cc ll (70-90% T ce ll s) 
Pan T cel l (> 95% T cel ls) 
Pan T cell (> 95%, T ce ll s) 
La ngerh ans celli 
indeterminate cell 
Natural ki ller/ ki ller 
Majori ty T ce ll 
(60 ± 10% Lcu-2+ T cd ls, 75 ± 10%, 
Leu-3 + T cells) 
Majority B cdls, 
sO ll1 e granulocytes, 
1l10nocy tcs, NK cel ls 
Majority T cd l 
(100% Lcu-2 I T cells. 90% Leu-3 ; T cell s) 
HLA-DQ 
HLA-DR 
Inrerlcukin-2 receptor 
Macrophage 
B ce ll 
Proli fe rating cel ls (a ll stages of the ce ll cycle) 
In Situ Quantitation ofT-Ceil Subsets in Allerg ic Contact Dermatitis 
Interval Percentage of Reactive T Cell s" 
Before Biopsy 
(days) Lcu-2 Leu-3 Leu-S Leu-9 Tac Ki-67 
I 5 95 60 60 N O ND 
I 5 95 60 60 N D N D 
2 5 95 50 67 5 0 
3 I 9') 60 75 N D ND 
3 25 75 SO 67 5 ND 
3 33 67 67 90 5 0 
3 20 80 33 75 5 I 
4 5 95 50 80 33 I 
7 5 95 90 90 33 10 
7 10 90 67 75 33 5 
7 20 SO 67 90 50 5 
Lcu-3 +S+b 
58-63 
58-63 
47-53 
60 
73-100 
51-100 
16-4 1 
47-53 
89-95 
63-74 
59-84 
• AIITlost all infiltrat ing lym pho id cells were T cells dcfined by reacti vity with Lell-I , Lell-4. and Leu-5. Leu-M3+ macrophages consti tuted less than 5% of the infiltrate 
in each casco B cclls and NK cells were absent or rarc . 
bMaxi ilium possible percenta ge of Leu-3 +8 + cel ls: Lcu-8 ~ ILcu-3 -1 or I OQlyo , w hichcVLT was sma ller. Minimum possibk percent age of Lcu-3 +8 + cells: (Leu-S '" minlls 
Lcu-2 + )/Leu-3+ or 0%, whichever was greater . 
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Fig ure 1. Pos iti vc pa tch tcs t to d ich ro l11ate,;;1t 3 da ys. T hc vast maj o rit y a i- in fi ltrat ing ce ll, a lT Lc u-4 +(A), Lc u- 3 +(/3), and Leu-8 ' (C). O nl y a s m a ll 
l11 ino rity arc Lcu-2 I (0 ). A ll fi gures: il11l11un o pcro x idasc w ith meth yle ne blu e coun tc rstain X 350. 
2). In 6 b iops ies, the m aj o rit y of T cell s we n: I-I LA-DR I . In 5 
bio psies, the min ority o f T ce ll s were H LA-D I ~ I. T he num ber 
o f H LA-DQ I T ce ll s tended to pa ra ll e l the nUl11 ber of I-I LA-
D I~ I T cc lls. 
Eig ht biopsies were stJ in ed fo r Tac, the in tc rleuki n-2 recepto r. 
In 4 o ft hesC', w hi ch w ere specimens obta in ed fro m positi ve patch 
tes t s itcs sa1l1 pled ;It 48-72 h . ap i rox im ate ly 5% o f the T ce ll s 
were pos it ive. In thc 4 ot her bio psies s ta in ed fo r Ta c, w hi ch were 
3 spccim en s fro 1l1 positive patch test s itcs sam plcd at 7 da ys , and 
I specim en fro lil Hhu s derm atitis sa mpl cd at 4 da ys. th e n u m be r 
of Tac I ce ll s ranged fro m 33-50% (m edi an 33%) (Fig 3). 
Seven b io psies w ere s tain cd w ith I< i-67 w hi ch dc fin cs a nu clea r 
an t igen presen t in active ly pro liferat in g ce ll s at all s ta ges of the 
ce ll cy clc. In 4 o f these. in cl ud in g 3 positive patch tes ts sall1p led 
at 48 or 72 ho u rs ;lIld 1 b iopsy of Rhu s derm at itis s3m plcd at 4 
da ys, no ne or rare I< i-67 , lymp ho id ce ll s we re id ent ifi ed . T he 
o ther 3 b io psies s ta in ed w ith I< i-67 were pos itivc patch tests sa m-
pled at 7 days w hi ch con t'lin ed 5- 10% l<i-67 I ly m pho id ce ll s 
(F ig 4). 
~ . 
... 
Fig u re 2. Pos itive patch test to quatcrniulll 15 aJ 7 da ys. /(cra tinocy tes 
ex hibi t l11ul t ifoca l react ivit y fo r H LA-DH showli here p redo min an tly in 
the r ig ht half o f the fl cld . E piderm al La nge rh :! ns ce ll s. n los t T ce ll s in-
fi ltrati ng the d erm is. and vascu lar endo thel ial ccll s arc also I-I LA-DR ' . 
Leu-(,I den dri t ic cc ll s Were g Cllcra ll y HL A-D I,( I and HLA -
DQ I . T hey werc in creased in the ep iderm is and the d ermis ill 7 
b iopsies. In 3 b iops ies, they were in crea sed in the dLT mis on ly, 
and in I b io psy they we re presen t in no rm al nUlll bers. T hese 
res ul ts d id no t co rrelate w ith the t im e of b iopsy . Le u-3 exp ression 
b y int rac piderlll al Leu-6 I dend ri tic ccll s was prcscn t in 5 b iopsies : 
I wea k. 2 m oderate, and 2 s tro ng . T he 2 bio psies in w hi ch d en-
d ri t ic ce ll s s ta in ed st ro ng ly Le u-3 " (i. e. ; co m parab le to T H cells) 
were ob tain ed fro lll posit ive patch tes t sites sa m pled at 7 da ys 
(Fi g 5). 
I< erat in o cy tes we re H LA-DR - and H LA - DQ - in all b iopsies 
except 3 that ex hib ited mul tifocal H LA - DR rea ct iv ity in th e lower 
o ne- ha lf of the epidermi s. T hese w ere fro ll1 pos itive patch tes t 
s ites sa m pled at 3 da ys ( I biopsy) o r 7 days (2 bi o psies) (Fig 2). 
A ll biops ies wsted con t.a in ed CIl dotheli al cel ls that were H LA-
J) I ~ I ( 11 / I I) and /-I LA- DQ I (6/6) . T he in tcnsity of these 2 reac-
tiv ities tended to be pa rallel altho ug h I-ILA-DR w as always m ore 
in tcnse (Fig 2). 
Leu M3 I m acrophages we re scatte red w ithin the pap ill ary dcr-
, 
Fig ure 3. Pos itive patch test !'O q uatcrni ll lTl 15 a t 7 da ys. A l1I ino rit y of 
infi ltrati ng T cell s (33 u;" overa ll in thi s case) we re Tal" . T;1C ex press io n 
w as g reates t in b io psies sam pled afte r day 3. 
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Figure 4, Posit ive patch test to quaterniul11 15 at 7 days. A minority of 
infi ltrati ng T cells (10% overall in this case) showed Ki-67 + nuclei, sug-
gesting proli ferative activity. Note the similar reacti vity of several nuclei 
within the basa l layer of the epidermis. 
m.is a n d occas io nall y within the epidermis. T hey constituted less 
than 5 % o f the infiltrate. Anti-Leu-S reactivity w ith macrophages 
or Langerhans cells was no t observed in these cases , nor has it 
been n o ted by us in reactive lymph nodes or tonsils [1]. Plasm a 
cell s, T015 + B cells, and Leu-7 '" NK cell s were absent or rare. 
DISCUSSIO N 
O ur in situ immuno histologic data indi ca te th at, analogous to in 
vitro s tudies of the MLR [l-3J, both Leu-S+ and Leu-S- subsets 
of Leu- 3 + T cells are present in cell-med iated immune reactions 
in v ivo. A majority o f Leu-3 + ,S + T cells w as present in most of 
our cases. Only the positi ve patch tes t to hydroxycitronellal sam-
pled at 3 days had a definite minority ofLeu-3 +8 + T cells. In the 
speeiulens we studied, we could not find any correlation between 
the duration of the inflammatory reaction and the number of Leu-
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3 +8 + cell s. Since Leu-3 +,S + T cells have the capacity to induce 
both suppressor and T e cells whi le Leu-3 +8 - T cells are known 
to induce onJy the latter, Leu-3 "', S + cells m ay be necessary fo r 
downgrad in g the immune response through the induction of sup-
pressor cells. It m ay not be necessary to have a majority of Leu-
3 + ,S + cells in o rder for suppression to occur since this funct ion 
may be qualitatively rather than strictly quantitatively determined. 
O ur res ults confirm those o f prio r immuno histologic studies 
o f allerg ic contact derm atitis w hich indi cate that the inflammatory 
mononuclear cell infi ltrate is co m posed predominantly of m ature 
T cells w ith a TH /T es (Leu-3 + ILeu-2 +) ratio rangin g fro m ap-
proxi m ately 1 : 1 to 10: I [5-9]. In one stud y, there was no cor-
relation bctwecn the T HIT es ratio and cither the typc of aJ lergen 
or thc tim e interval prio r to biopsy [S1. In apother study, the 
numbcr ofTH was increased o r sta ble over time w hile the number 
of T es was dccreased or stable [5] . In a recent study of a variety 
of benign inflammatory conditions, the majority of T cells were 
Lcu-9 + in almost every case [1 0]. In thc current study, the m a-
j o rity ofT cells were also Leu-9 +. T his find ing is no t unexpected 
since the Leu-9 antigen is expressed by thc m aj ority of norm al T 
cells in the blood and lymphoid tissues [11]. 
In contras t to the genera l predo minance of Lcu-S+ and Leu-9 + 
T cells observed in allergic contact derm atitis, we and others have 
noted a defi ciency of these antigcns in m any cases of m ycosis 
fun goides and Sezary syndro me and in T-cell lym pho m a cell lines 
[1 0, 12-16]. These contrasts suggest th at immuno pheno typic cri-
te ria can be cstablished to help distinguish T - cell lymph o m a from 
benign inflammation . C urrent work by ou r group exa mining a 
large scries of m ycosis fu ngoides patients and controls, supports 
this concept. 
Tac is the receptor for interleukin-2, a m o lecule w hich pro-
m otes cell-mediated immunity by inducing pro li ferat ion ofTac + 
T cell s [1 7]. O ur data suggest a direct correl ation between the 
duratio n of the inflammatory res ponse and th e nun~ber o f Tac + 
cells. This suggests th at it m ay take several days to induce expres-
sion of this receptor by T cells in vivo. 
Ki-67 recognizes a lineage-nonspecific nuclear antigen ex-
pressed by actively proliferating cells at all stages of the cell cycle 
[1 S1· Our data suggest that T cells in allergic contact derm atitis 
can replicate in situ but that this activi ty, li ke Tac expression, 
m ay require several days to occur. 
We found that Leu-6 + dendriti c cells w ithin th e epidermis and 
dermis were genera lly increased in number and admixed with the 
infiltrating T cells. T his is in agreement w ith prior studies of 
allergic contact dermatitis. In one quantitative study, epiderm al 
Figure 5. Positive patch tcst to quatcrnium 15 at 7 days. Lcu-6 + dendritic cclls (Langerhans cells/indcterminate cells) arc increased in cpidermis and 
dermis (A). Many of these dendritic cells are also Lcu-3 + with an intensity similar to that seen within the dermal T cells (8). Onl y occasional nondcndritic 
Leu-4 + T ce lls are prcsent with in the epidermis and cannot account for the intraepidermal dendri tic pattcrn of Leu-3 reactivity (C). 
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OKT6 + cells were mildl y increased relative to controls while 
derma l dendriti c cells comp rised from 20- 50% of th e total derma l 
infiltrate [8]. Another quantitati ve study of Langer hans cells within 
the epidermis also found them to be increased [5]. When exa mined 
over tim e, most OKT6 + cells were initiall y found in the epidermis 
(1-2 days), then in the dermis (4-14 days), and then once aga in 
in the epidermis (21 days) [7J. 
In some biopsies, there was Leu-3 ex pression by intraepidermal 
Leu-6 + dendritic cells. Leu-3/T4 expression by cells of Langer-
hans lineage has been previously docum ented at both the light-
mi croscopic and ultras tru ctural levels [1 9-22]. This ex pression 
appears to occur predom inant ly in skin containing a T-cell inftl-
trate [22]. It was interes ting in our study that the 2 biopsies in 
whi ch the Leu-6 + epidermal cells stain ed strongly for Leu-3 were 
those obtained from patch tes t sites sa mpled at 7 days. It is possible 
that Leu-3 expression by Langerh ans cell s may be time-depen-
dent. Altern atively, it may be genetica ll y variable. 
B cells and natural killer (NK) cells were absent or rare in our 
series. This has been the genera l experience [6- 9] although one 
report [8J described B cells including germina l centers in 2 of 19 
cases o f positive patch tests. The fact that in our stud y th e majority 
of Leu-3 '" T cell s were Leu-8'" in most biopsies, may correlate 
at least in part w ith the paucity of B cells and plasma cells since 
Leu-3 + ,8 - T cells provide the major help fo r B cell differentiation 
into plasma cells, and Leu-3+ cells within the germin al centers 
of reactive B cell fo lbcl es are virtuall y all Leu-8 - [1] . 
T he epidermal staining pattern s observed by some investigators 
suggest that there is vari able expression of HLA-DR by kerat-
inocytes and end othelial cells in contact dermatitis [5 ,8,9,23- 25] . 
In our study , all biopsies contained HLA-DR + endothelial cells 
althoug h we did not find extensive expression of HLA-DR an-
tigen by keratinocytes, as there was on ly l11ultifocal positivity in 
3 of 11 biopsies. It has been shown that HLA-DR expression by 
endothelial cell s and keratinocy tes can be induced by y-interferon 
in vitro [26,27]. HLA-DR expression by keratinocytes in allergic 
contact dermatitis may occur by a similar mechanism. Two of 
th e 3 cases containing HLA-DR + keratinocytes were sa mpled at 
7 days. T his sugges ts th at there may be a tim e requirement for 
HLA-DR expression by human keratinocytes in vivo. This 
express ion generall y does not become max imal until day 3-4 in 
vitro [28J. In te rl eukin-2 promotes both expression of its receptor 
(Tac) and y-interferon synthesis by T cell s [1 71. T his may help 
to explain HLA-DR + keratinocytes and Tac + T cell s in our cases; 
however, th ese 2 features did not always co rrel ate within indi-
vidual biopsies . T hese res ults contrast with recent data derived 
from a lllurine model of allergic contact dermatitis whi ch suggests 
th at keratinocy te Ia expression is a rela tively early transient event 
that precedes cutaneous infilt rat ion by T cell s [25]. 
We were unable to detect HLA-DQ expression by keratino-
cytes . T his is consistent wi th prior in vitro studies in which 
y-interferon was unable to induce HLA-DQ expression by ke-
ratinocytes [28]. However, recent studies of mycosis fun goides 
sugges t that HLA-DQ can be expressed by keratinocytes but that 
this may require a time interval greater than that included in our 
study [29] . 
In summary, our in situ studies of allergic contact dermatitis 
are consistent w ith in vitro studies of the allogeneic MLR which 
indica te that both Leu-3 + 8 + and Leu-3 '" 8 - T cell subsets are 
involved in cell-mediated im munity. Expression of Tac and Ki-
67 by T cells and Leu-3 by Langerhans cells can occur in allergic 
contact dermatitis and appea rs to exhibit a trend toward increase 
over tim e. In contrast to T cells and endothelial cells, expression 
of class " MHC anti gens by keratinocy tes w ithin the first week 
after exposure to contact all ergens was not a prominent feature 
of our series . 
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